Christopher M. Smith

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
5 years
Director since
2023

5 years of board service in total across 2 boards, counting each seat separately. Longest: QuidelOrtho Corporation, 3 years.

3 years · Since 2023
1 year · Since 2025

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 23, 2025 NeoGenomics Inc. Option exercise +57,413 — —
Feb 23, 2025 NeoGenomics Inc. Shares withheld for tax −14,067 — —
Jan 30, 2025 Pacific Biosciences of California Inc. Grant or award +54,099 — —
Aug 15, 2024 NeoGenomics Inc. Shares withheld for tax −33,130 — —
May 11, 2024 NeoGenomics Inc. Option exercise +48,063 — —
May 11, 2024 NeoGenomics Inc. Shares withheld for tax −18,913 $14.86 $281,047
May 11, 2024 NeoGenomics Inc. Option exercise +48,063 — —
Jun 6, 2023 QuidelOrtho Corporation Grant or award +2,248 — —
May 27, 2023 QuidelOrtho Corporation Shares withheld for tax −1,225 $85.54 $104,787

Questions about Christopher M. Smith

What boards is Christopher M. Smith on?

Christopher M. Smith sits on the boards of Pacific Biosciences of California Inc. and QuidelOrtho Corporation.

How long has Christopher M. Smith served on boards?

Our records show at least 5 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.